NCT05124002 2024-03-04
Recombinant Human Adenovirus Type 5 Plus HAIC of FOLFOX for Intrahepatic Cholangiocarcinoma
Beijing Tsinghua Chang Gung Hospital
Phase 4 Unknown
Clinical Trials
56 trialsNCT01515787 2024-02-02
PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery
Alliance for Clinical Trials in Oncology
Phase 2/3 Unknown
NCT06123455 2023-11-08
Clinical Study of Taurine Combined With Sintilimab and Chemotherapy for Treatment of Advanced Gastric Cancer
Tang-Du Hospital
Phase 2 Unknown
NCT06115174 2023-11-02
CRC - PTX
Tanta University
Phase 4 Unknown
NCT00958737 2023-09-29
IDEA
GERCOR - Multidisciplinary Oncology Cooperative Group
Phase 3 Unknown
NCT06003998 2023-08-22
INTERACT-II
Catharina Ziekenhuis Eindhoven
Phase 2 Unknown
NCT05099848 2023-08-15
A Trial of Conversion Treatment of HAIC Combined With Camrelizumab and Apatinib for Unresected Hepatocellular Carcinoma
Shandong Cancer Hospital and Institute
Phase 2 Unknown
NCT05832398 2023-06-28
Precision Chemotherapy Based on Organoid Drug Sensitivity for Colorectal Cancer
Nanfang Hospital, Southern Medical University
Phase NA Unknown
NCT04962958 2023-06-22
Hepatic Artery Infusion Chemotherapy Plus Donafenib in Patients With Hepatocellular Carcinoma After Surgery
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 2 Unknown
NCT05886465 2023-06-02
HAIC Plus A+T for Patients With High-risk HCC: a Single-arm Phase 2 Trial
Sun Yat-sen University
Phase 2 Unknown
NCT02974556 2023-05-06
PROMENADE
University of Roma La Sapienza
Phase 3 Unknown
NCT05797883 2023-04-04
FOLFOX/FOLFIRI Containing Levofolinic Acid (Zuoyu ®) in the Treatment of Unresectable or Metastatic Colorectal Cancer
China Medical University, China
Phase 2 Unknown
NCT05721872 2023-02-10
Efficacy, Tolerability and Safety of Intravenous D-VC With ATO in Patients With Advanced/Metastatic Colorectal Cancer
Nazarbayev University
Phase 1/2 Unknown
NCT05029973 2023-02-08
HAIC Combined With Sintilimab and Bevacizumab Biosimilar for Unresectable HCC
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Unknown
NCT03883802 2022-12-09
NeoFox
WntResearch AB
Phase 2 Unknown
NCT05617430 2022-11-15
Combination Therapy of HAIC, Sintilimab and Bevacizumab for Advanced Hepatocellular Carcinoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 2 Unknown
NCT05535647 2022-09-10
Second Line Therapy for Advanced Intrahepatic Cholangiocarcinoma
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Unknown
NCT05493332 2022-08-18
HAIC Combined With Donafenib Tosilate and Toripalimab for Unresectable HCC
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 2 Unknown
NCT05494320 2022-08-09
the Effect of ABCC2 Genetic Polymorphism on Neurotoxicity in Gastrointestinal Cancer Patients Receiving Oxaliplatin
Ain Shams University
Unknown
NCT03666832 2022-06-15
MP-PDAC-01
Samsung Medical Center
Phase 1/2 Unknown
NCT02839343 2022-05-24
Combination Chemotherapy With or Without Hypofractionated Radiation Therapy Before Surgery in Treating Patients With Pancreatic Cancer
Alliance for Clinical Trials in Oncology
Phase 2 Unknown
NCT05231382 2022-05-24
Hepatic Arterial Infusion of Raltetrexed With Oxaliplatin(SALOX) Versus FOLFOX in Advanced Hepatocellular Carcinoma
Sun Yat-sen University
Phase 3 Unknown
NCT05352165 2022-04-28
The Clinical Efficacy of Drug Sensitive Neoadjuvant Chemotherapy Based on Organoid Versus Traditional Neoadjuvant Chemotherapy in Advanced Rectal Cancer
Shanghai Minimally Invasive Surgery Center
Phase NA Unknown
NCT03940131 2022-04-06
REPAN
King Abdullah Medical City
Phase 2 Unknown
NCT03957733 2022-04-06
Phase II/III Study to Assess the Efficacy of Neoadjuvant Consolidation Chemotherapy in Rectal Cancer Patients.
King Abdullah Medical City
Phase 2/3 Unknown
NCT03939962 2022-01-26
Camrelizumab Combined With FOLFOX Neoadjuvant Therapy for Resectable Gastric and Gastroesophageal Junctional Adenocarcinoma
Henan Cancer Hospital
Phase 2 Unknown
NCT04621370 2020-11-09
PRIME-RT
Cancer Research UK, Glasgow
Phase 2 Unknown
NCT04167007 2020-08-18
GEMFOX
Assistance Publique - Hôpitaux de Paris
Phase 3 Unknown
NCT04303429 2020-04-08
Adjuvant Chemotherapy in High Risk Stage II Colon Cancer
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase 3 Unknown
NCT04155671 2019-11-07
POF Versus FOLFOX Plus IP Paclitaxel in AGC
Fujian Cancer Hospital
Phase 2 Unknown
NCT01923987 2019-09-20
Short Course Radiotherapy Followed Intensive Chemotherapy With Delayed Surgery for Rectal Cancer With Synchronous Distant Metastasis
Korea Cancer Center Hospital
Phase 2 Unknown
NCT02002195 2019-02-27
MATURE
International Group of Endovascular Oncology
Unknown
NCT02486601 2019-02-27
FOXAGAST
GERCOR - Multidisciplinary Oncology Cooperative Group
Phase 2 Unknown
NCT03812783 2019-01-23
HAIC of FOLFOX Plus Sorafenib vs HAIC of FOLFIRINOX Plus Sorafenib for Advcanced HCC
Sun Yat-sen University
Phase 2 Unknown
NCT03469479 2018-08-02
Neoadjuvant HAIC for Resectable Hepatocellular Carcinoma Beyond Milan Criteria
Sun Yat-sen University
Phase 3 Unknown
NCT03377842 2017-12-19
Apatinib Treatment as the Neoadjuvant Therapy in Advanced Colorectal Cancer
Sichuan Provincial People's Hospital
Phase 2 Unknown
NCT03280407 2017-09-28
NEOLAR
Zealand University Hospital
Phase 2 Unknown
NCT02738697 2016-11-02
Adjuvant Chemotherapy With FOLFOX in HCC Patients After Resection
Sun Yat-sen University
Phase 3 Unknown
NCT02882269 2016-08-30
Neoadjuvant Chemotherapy for the Treatment of Resectable Locally Advanced Colon Cancer
The First Affiliated Hospital with Nanjing Medical University
Phase 2/3 Unknown
NCT02215837 2016-05-24
Study of Autologous Tumor Lysate-pulsed D-CIK Combined With Chemotherapy for Gastric Cancer
Shenzhen Hornetcorn Bio-technology Company, LTD
Phase 2 Unknown
NCT02202928 2015-12-28
Adoptive Cell Therapy Plus Chemotherapy and Radiation After Surgery in Treating Patients With Colorectal Cancer
Shenzhen Hornetcorn Bio-technology Company, LTD
Phase 2 Unknown
NCT02590367 2015-12-02
Estimate the Efficacy of HD6610 Granule for Oxaliplatin-induced Peripheral Neuropathy
Jiangsu Province Hospital of Traditional Chinese Medicine
Phase 2/3 Unknown
NCT02452853 2015-05-25
HR Combined With FOLFOX4 for HCC With PVTT
Sun Yat-sen University
Phase 2 Unknown
NCT00004206 2014-06-24
Oxaliplatin and Fluorouracil in Treating Patients With Recurrent Ovarian Cancer
National Cancer Institute (NCI)
Phase 2 Unknown
NCT02128425 2014-05-07
FOLFOXIRI Compared to FOLFOX in First Line Treatment of Metastatic Colorectal Cancer
Sun Yat-sen University
Phase 2 Unknown
NCT00008281 2014-01-06
Comparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00006479 2011-04-18
Surgery With or Without Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00813137 2009-12-08
FOLFOX4 Combined With Endostar in Patients With Advanced Colorectal Cancer
Simcere Pharmaceutical Co., Ltd
Phase 2 Unknown
NCT00884767 2009-07-08
Biomarkers in Predicting Neurotoxicity in Patients With Colorectal Cancer Receiving Oxaliplatin
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00854854 2009-05-18
Efficacy Study of TKcell in Advanced Gastric Cancer
Binex
Phase 1/2 Unknown